Related Experiment Video
Updated: Feb 3, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
6.2K
Technology in Diabetes Treatment: Update and Future
Ralf Schiel1, Rolf Bambauer2, Antje Steveling3
1MEDIGREIF-Inselklinik Heringsdorf GmbH, Fachklinik für Kinder und Jugendliche, Ostseebad Heringsdorf, Germany.
Artificial Organs
|October 19, 2018
Summary
The increasing prevalence of diabetes mellitus necessitates advanced self-management and control strategies. New technologies, including glucose monitoring and insulin delivery systems, are vital for improving diabetes care and patient outcomes.
Area of Science:
- Endocrinology
- Medical Technology
- Public Health
Background:
- Diabetes mellitus is a growing global health concern, contributing significantly to mortality.
- Effective diabetes management hinges on patient self-management and achieving optimal glycemic control.
- Technological advancements are increasingly integrated into diabetes therapy.
Purpose of the Study:
- To provide an overview of emerging technologies in diabetes mellitus management.
- To highlight the role of new technological approaches in patient care.
- To serve as a spotlight on current innovations in diabetes technology.
Main Methods:
- Review of current technological advancements in diabetes care.
- Discussion of electronic tools for monitoring and patient education.
- Examination of real-time continuous glucose monitoring and insulin infusion systems.
Main Results:
- Widespread adoption of technologies such as real-time continuous interstitial glucose monitoring and continuous subcutaneous insulin infusion (CSII).
- Integration of electronic tools for therapeutic monitoring, automated bolus calculations, and patient education.
- Emphasis on the collaborative efforts between patients, caregivers, researchers, and industry.
Conclusions:
- New technologies play a crucial role in enhancing diabetes self-management and control.
- The rapid evolution of technology requires ongoing research to assess long-term benefits.
- Further studies are essential to validate the efficacy and impact of these devices.
Related Concept Videos
01:20Pathophysiology of Diabetes
3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
01:31Hybridoma Technology
17.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.7K
01:15Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
01:19Psychoneuroimmunology: Diabetes and Cancer
500
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
500
01:30Health Information Technology and Healthcare Information System
3.4K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.4K
01:22Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K